29 January 2025 - PHARMAC is reviewing and reconsidering its oestradiol patch options after considerable feedback was received when it announced a move to a single funded brand late last year.

PHARMAC is working with the suppliers of Estradot and Estradiol TDP Mylan on an updated proposal to make more than one brand of patches available beyond December 2025. The team is working on the proposal and aims to ask for feedback, in a public consultation, in late February.

Read PHARMAC press release